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A B S T R A C T
The aim of the study was to investigate the clinical association of multiple sclerosis and pars planitis (or intermedi-
ate uveitis), as well as to determine the incidence of pars planitis in multiple sclerosis patients. During the period of one
year authors examined 42 patients with multiple sclerosis divided into two groups. First group consisted of 23 patients
with history of optic neuritis and the second group consisted of 19 patients who have never had optic neuritis. The
mean age of patients in the first group was 31.7±5.1 years and in the second group 29.1±8.1 years. Pars planitis was
found in 12 patients with multiple sclerosis. Age, sex and degree of neurological disability had no influence on the ap-
pearance of pars planitis. Although optic neuritis is considered to be the most common ocular manifestation of multiple
sclerosis, the significant number of patients with multiple sclerosis has pars planitis.
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Introduction
Multiple sclerosis (MS) is characterized with inflam-
mation and multifocal damage to myelin in the central
nervous system. This disease could manifest with vari-
ous neurological signs and symptoms in relapsing-rem-
miting or chronic-progressive form. Ophthalmic symp-
toms are common in multiple sclerosis patients and
optic neuritis is considered to be the most frequent ocu-
lar manifestation. Ocular motility disturbances can be
also found in MS patients quite often1,2. Association be-
tween multiple sclerosis and pars planitis has been re-
ported in literature and the prevalence of intermediate
uveitis or pars planitis in MS patients is higher then in
the general population. The proportion of presence of
pars planitis in MS patients is from 3% up to 27%3. Pars
planitis, first described as chronic cyclitis by Schepens
is the term which describes snow banks, snow flakes
and snow balls with vitreus condensation over the infe-
rior peripheral retina and pars plana usually in both
eyes3,4.
Material and Methods
This study included 42 patients with multiple sclero-
sis. Multiple sclerosis was diagnosed according to Po-
sers' criteria5. Neurologic deficit and dysfunction were
recorded as scores according to the Expanded Disability
Status Scale (EDSS)6. During period of one year pa-
tients were identified and examined in a standardised
procedure at Neuroophthalmological division of Depart-
ment of Ophthalmology, University Hospital Center
»Zagreb«, in order to investigate the clinical association
of multiple sclerosis and intermediate uveitis and were
devided into 2 groups. 1st group consisted of 23 patients
with history of optic neuritis and 2nd group of 19 pa-
tients without history of optic neuritis. Standard oph-
thalmologic examination consisted of visual acuity mea-
surement with a Snellen chart, biomicroscopy, ophthal-
moscopy, and applanation tonometry. MS patients with-
out signs of pars planitis were examinated on three oc-
casions at a 4 months interval. MS patients with pars
planitis were examinated in one-month interval. Every
patient with intermediate uveitis and/or vitritis under-
went an evaluation for possible infectious etiology or as-
sociated systemic disorders. This evaluation included a
detailed medical and family history, clinical examina-
tion, laboratory testing, determination of angiotensin
converting enzyme and lysozyme levels in serum, and
chest X-ray when necessary. The presence of systemic
vasculitis, chronic bacterial or viral infections had been
excluded in all patients with intermedate uveitis. Pa-
tients with laboratory abnormalities or clinical histories
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suggestive of another etiology for their intermediate
uveitis were excluded from the study. The statistic dif-
ference degree between tested groups is determined by
variance analysis and Fisher exact test was used to de-
termine the prevalence of the presence of intermediate
uveitis according to sex in both groups. p-values <0.05
were considered statistically significant.
Results
Demographic and clinical features
During the period of one year, we examined a total
number of 42 patients with multiple sclerosis in order to
determine incidence of pars planitis in MS patients. 14
(61%) patients from the group of patients with history of
optic neuritis were females and 9 (39%) were males. In
the second group, which consisted of MS patients with-
out history of optic neuritis, 11 (58%) were females and
8 (42%) were males (Table 1).
Pars planitis was found in 7 (30%) patients with his-
tory of optic neuritis and 5 (26%) in patients without
history of optic neuritis. Clinical and demographic data
are shown in Table 2.
Treatment regiments
Four patients with pars planitis received between
four and seven periocular steroid injections in both eyes.
Five patients were treated with corticosteroid drops and
ointment and other three patients have received no
therapy.
Visual outcomes
Three patients had reduced visual acuity at baseline.
But on last control examination two of these patients
had normal visual acuity. During follow up one patient
had reduced visual acuity due to worsening of pars
planitis on second examination. But after several perio-
cular steroid injections visual acuity has recovered to
1.0 vision. The other eight patients had normal visual
acuity during one year follow up.
There was no correlation between the degree of neu-
rological disability (EDSS), age or sex with the presence
of intermediate uveitis.
Discussion
Intermediate uveitis or pars planitis is characterized
by inflammatory deposits in the area of pars plana and
it is tipically bilateral. The presence of vitreal cells in an
active vitritis could be the first observable sign of pars
planitis. The vitritis will frequently result in an accu-
mulation of inflammatory exudate. The accumulation
may be small (snowballs) or extensive (snowbanks). Pa-
tients are frequently asymptomatic, but may present
with modestly diminished vision that is slowly progres-
sive, as well as complaints of floaters. This condition can
be found in the literature under the other names such as
chronic cyclitis, peripheral uveitis and others. In 1987
International Uveitis Study group approved the term
intermediate uveitis. This term contains other kind of
inflammation named as cyclitis, vitritis, peripheral
uveitis and pars planitis1,7,8. The origin of intermediate
uveitis is unknown but histopatologic studies suggest a
possible autoimmune basis for pars planitis. Intermedi-
ate uveitis coud be idiopathic or associated with various
systemic diseases. Athough optic neuritis is considered
the most common ocular manifestation of multiple scle-
rosis, significant number of MS patients could have in-
termediate uveitis2–4,9–12. In 1953 Wuseke13 described
association between MS and pars planitis. Since then
many investigators have reported linkage of multiple
sclerosis and pars planitis. The pathogenetic relation-
ship between uveitis and multiple sclerosis is unknown.
Bennett and all suggest that an autoimmune response
to common antigenetic factor existing in both the uvea
and CNS is responsible for the occurrence of uveitis
with MS in susceptible individuals1. Incidence of pars
planitis in MS patients varied from 3% to 27%3,14,15. In
our research we have found that 28,5% of MS patients
have pars planitis. This variation of incidence could be
attributed to variations in diagnostic criteria and classi-
fication. Pars planitis is condition which can be treated
with coricosteroids (topical or oral), or in severe cases
immunosupresive therapy3,16. We have treated our pa-
tinets with periocular steroid injections and steroid
drops and ointment. The indications for periocular ste-
roid injections were decreased visual acuity and the
presence of acute signs of intermediate uveitis and
vitritis. In other cases steroid drops and ointment were
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TABLE 1
DEMOGRAPHIC AND CLINICAL DATA
Group MS patients with history
of optic neuritis
MS patients without history
of optic neuritis
N 23 19
Age range (years) (mean±SD) 24–41 (31.74±5.08) 25–40 (29.13±8.1)
Female N (%) 14 (61%) 11 (58%)
Male N (%) 9 (39%) 8 (42%)
MS duration range (years) (mean±SD) 1–8 (4.22±1.88) 1–11 (3.26±2.42)
EDSS* (mean±SD) 1–6 (2.72±1.13) 1–3.5 (2.18±0.79)
*EDSS – An expanded disability status scale according to Kurtzke6
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administrated. Raja et al3 quoted that indication for
therapy was decreased visual acuity to 0.5. Besides
corticosteroid therapy their patients were also treated
with azathioprine or cyclosporine3. Visual outcome in
pars planitis is generally good. Only 4 our patients with
pars planitis had reduced visual acuity. In 3 patients vi-
sual acuitiy has recovered to 1.0. More pronounced vi-
sual acuity impairment is caused by cystoid macular
edema, cataract and epiretinal membrane. No patient
in our study has this kind of complication and therefore
visual outcome in our patients is good. Given the small
number of patients, the proportion with decreased vi-
sion in the long term could be higher and not have been
detected in our study.
In conclusion, intermediate uveitis can be found in
significant number of patients with multiple sclerosis.
Since patients are frequently asymptomatic, MS pa-
tients shoud be examined carefully in order to avoid
misdiagnosis.
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TABLE 2
CLINICAL DATA ON PATIENTS WITH PARS PLANITIS
Group MS patients with history
of optic neuritis
MS patients without history
of optic neuritis
N 7 5
Age range (years) (mean±SD) 24–41 (32.71±5.96) 27–31 (28.8±2.05)
Female N (%) 4 (57%) 3 (60%)
Male N (%) 3 (43%) 2 (40%)
Reduced visual acuity, N 3 1
Presence of subjective signs, N 5 3
Conjunctival hyperaemia, N 4 3
Presence of snow balls and flakes, N 7 5
Presence of snow banks, N 2 1
Presence of vitritis, N 7 5
Therapy with periocular steroid injections, N 3 1
Therapy with steroid drops and ointment, N 2 3
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POJAVNOST PARS PLANITISA U MULTIPLE SKLEROZE
S A @ E T A K
Cilj ove studije je bio istra`iti klini~ku povezanost opti~kog neuritisa i multiple skleroze, kao i odrediti u~estalost
pars planitisa u bolesnika s multiplom sklerozom. Tijekom godinu dana pregledano je 42 bolesnika s multiplom skle-
rozom koji su podijeljeni u dvije skupine. Prva skupina sastojala se od 23 bolesnika koji su imali opti~ki neuritis, dok
je u drugoj skupini bilo 19 bolesnika bez opti~kog neuritisa. Prosje~na dob bolesnika prve skupine bila je 31,7 ± 5,1
godina, a druge skupine 29,1 ± 8,1 godina. Pars planitis je na|en u 12 bolesnika s multiplom sklerozom. Dob, spol i
stupanj neurolo{kih ispada nisu imali utjecaja na pojavnost pars planitisa. Iako se opti~ki neuritis smatra naj~e{}om
oftalmolo{kom manifestacijom multiple skleroze, zna~ajan broj bolesnika s multiplom sklerozom ima pars planitis.
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